Skip to main navigation
X4 Pharmaceuticals
  • About
  • our medicine
  • science & pipeline
  • Patients
  • healthcare professionals
  • Investors
    • Company Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
    • Investor FAQs
  • Careers
X4 Pharmaceuticals X4 Pharmaceuticals
  • About
  • our medicine
  • science & pipeline
  • Patients
  • healthcare professionals
  • Investors
    • Company Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
    • Investor FAQs
  • Careers

News Releases

December 4, 2024
PDF Version
X4 Pharmaceuticals to Present Trial-in-Progress Poster on Phase 3 Study of Mavorixafor in Chronic Neutropenia at 66th ASH Annual Meeting & Exposition
December 3, 2024
PDF Version
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 26, 2024
PDF Version
X4 Pharmaceuticals to Participate in the 36th Annual Piper Sandler Healthcare Conference
November 14, 2024
PDF Version
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
November 13, 2024
PDF Version
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
PDF Version
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)
November 1, 2024
PDF Version
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 24, 2024
PDF Version
X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024
October 1, 2024
PDF Version
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 3, 2024
PDF Version
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 29

quick links

Quick Links

  • About
  • Patients
  • Investors
  • Careers
footer logo

contact

X4 Pharmaceuticals
61 North Beacon Street
4th Floor
Boston, MA 02134 Phone: 857.529.8300

X4 Pharmaceuticals (Austria) GmbH
Helmut-Qualtinger-Gasse 2
A-103 Vienna, Austria Phone: +43.1.395078300
© 2024 X4 Pharmaceuticals, Inc. All rights reserved.  

Live - Footer

Terms of Use | Privacy | Compliance and Ethics